Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07210229 · ClinicalTrials.gov registry record · NA
The Effectiveness of a Proprietary Ashwagandha Extract on Menopausal Symptoms: A Three-Arm Randomized, Double-Blinded, Placebo Controlled Clinical Trial
A NA study, sponsored by Nutraceuticals Research Institute.
- Not yet
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07210229 is a NA study that has not yet begun recruiting, run by Nutraceuticals Research Institute. The registered enrollment target is 90 participants.
The verdict
NCT07210229, a NA study, has not yet begun recruiting, sponsored by Nutraceuticals Research Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of two proprietary ashwagandha extracts on symptoms of menopause and hormone levels, as compared to a placebo.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT ashwagandha root
- DIETARY_SUPPLEMENT ashwagandha root and leaf
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2026-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07210229
The ClinicalTrials.gov registry entry for NCT07210229 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nutraceuticals Research Institute, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT07210229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07210229 about?
NCT07210229 is a clinical study titled "The Effectiveness of a Proprietary Ashwagandha Extract on Menopausal Symptoms: A Three-Arm Randomized, Double-Blinded, Placebo Controlled Clinical Trial". The purpose of this study is to evaluate the efficacy of two proprietary ashwagandha extracts on symptoms of menopause and hormone levels, as compared to a placebo.
What is the current status of trial NCT07210229?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2025-10-01. Estimated completion is 2026-03-30.
What interventions are being tested in trial NCT07210229?
The interventions under investigation include: Placebo (OTHER), ashwagandha root (DIETARY_SUPPLEMENT), ashwagandha root and leaf (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07210229?
This trial is sponsored by Nutraceuticals Research Institute, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.